Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
888.3 USD | -0.27% | -2.12% | -0.05% |
02:45pm | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
Apr. 25 | Regeneron Pharmaceuticals Receives a Shareholder Proposal from John Chevedden | CI |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.